Web Results

Critical appraisal of the use of matrix metalloproteinase inhibitors in ...

www.nature.com/onc/journal/v19/n56/full/1204097a.html

Bayer and Agouron have discontinued their ongoing Phase III drug trials of ... Since MMPs also play an important role in tumor angiogenesis (Fang et al., ... et al., 1998; Nelson et al., 2000; Parsons et al., 1997; Wojtowicz-Praga et al., 1997). ..... was developed by Bayer Corporation with selective for MMP-2, MMP-9, MMP- 11, ...

Adult hippocampal neurogenesis and pattern separation in DG: a ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4542503/

Aug 20, 2015 ... Although discrimination of similar contexts (Niibori et al., 2012; Deng et al., .... DGCs reside (Altman and Bayer, 1990; Espósito et al., 2005; Laplagne et al., .... 10.1002/hipo.20095 [PubMed] [Cross Ref]; Becker S., Wojtowicz J. M. (2007). ... J. F., Ramirez-Amaya V., Lipa P., Hoffman K. L., Marriott L. K., et al.

Bayer v. Beran | Casebriefs

www.casebriefs.com/blog/law/corporations/corporations-keyed-to-klein/the-duties-of-officers-directors-and-other-insiders/bayer-v-beran/

Bayer v. Beran. Share. Share on Facebook Share on Google+ Email this to ..... Plaintiffs, Bayer et al., filed a derivative shareholder action against Defendant ...

A phase I dose escalation study of the matrix metalloproteinase ...

annonc.oxfordjournals.org/content/11/12/1579.full.pdf

status of s£ 2 and a life expectancy of at least 12 weeks, and v) absolute granulocytes >1.5 x 109/l, ..... Data on file with Bayer Corporation, West Haven, Connecticut. 18. Wojtowicz-Praga S. Torn J, Johnson M et al. Phase I trial of marimastat ...

Targeting the TGFβ pathway for cancer therapy - ScienceDirect

www.sciencedirect.com/science/article/pii/S0163725814002010

Nov 6, 2014 ... (Calon et al., 2012) demonstrated that constitutively TGFβ-pathway inactive ... NovaRx Corporation®, TGFβ2, NCT01058785 ..... Bayer, and Lilly; and Eric Raymond is a consultant for Pfizer, Novartis, Bayer, and Lilly. .... Kim et al., 2008; S. Kim, G. Buchlis, Z.G. Fridlender, J. Sun, V. Kapoor, G. Cheng, et al.

Adult hippocampal neurogenesis of mammals: evolution and life ...

rsbl.royalsocietypublishing.org/content/5/1/141

Feb 23, 2009 ... 1996; Gould et al. 1999; Ben Abdallah et al. in press), albeit with considerable species differences. ... Altman J,; Brunner R.L,; Bayer S.A. 1973 The ... Amrein I,; Boonstra R,; Lipp H.P,; Wojtowicz J.M .... Lindsey B.W,; Tropepe V.

IFNL4 ss469415590 Variant Is Associated with Treatment Response ...

www.hindawi.com/journals/ijh/2014/723868/

Nov 24, 2014 ... Hindawi Publishing Corporation. Home · Journals .... Bibert et al. ... HCV RNA was measured by COBAS AMPLICOR HCV Monitor test v.

Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 ...

link.springer.com/article/10.1023/A:1025473709656

... Ishikawa, Japan; 3. Department of Pharmacokinetics and Drug Metabolism, Bayer Corporation, Pharmaceutical Division, West Haven, Connecticut, USA ...

Development of musculoskeletal toxicity without clear benefit after ...

arthritis-research.biomedcentral.com/articles/10.1186/ar2315

Oct 24, 2007 ... Krzeski et al.; licensee BioMed Central Ltd. 2007 ...... Unchanged vs. baseline ... In an attempt to minimize these effects, Bayer Corp. .... View ArticlePubMed; Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, ...

Full Text - Clinical Cancer Research

clincancerres.aacrjournals.org/content/5/11/3603.full

The method described by Passaniti et al. .... A. M. C. is a consultant for Bayer Corp. ... Wojtowicz-Praga S. M., Dickson R. B., Hawkins M. J. Matrix ... Belotti D., Vergani V., Drudis T., Borsotti P., Pitelli M. R., Viale G., Giavazzi R., Taraboletti G.

More Info

Age-related changes in dentate gyrus cell numbers, neurogenesis ...

www.ncbi.nlm.nih.gov

Jul 14, 2015 ... Similarly, also using functional MRI, Yassa et al. ... progressive declines (Kuhn et al., 1996; Seki, 2002; McDonald and Wojtowicz, 2005). .... Toolkit (version 6.75. 10; Bioquant Image Analysis Corporation, Nashville, TN, USA). ... and by the Cavalieri principle utilizing Vref = T x ΣA1-n (Gundersen and Jensen, ...

Phase I and Pharmacologic Study of the Specific Matrix ...

jco.ascopubs.org

Jan 1, 2000 ... BAY 12-9566 was supplied by Bayer Corporation, Pharmaceutical Division (West ..... Wojtowicz-Praga S, Torri J, Johnson M, et al: Phase I trial of .... Levy TD, Cioce V, Sobel ME, et al: Increased expression of the Mr 72,000 ...

Judge Cathy Seibel - PlainSite

www.plainsite.org

... Eland v. Bayer Healthcare Pharmaceuticals Inc et al ... v. Bayer Healthcare Pharmaceuticals Incorporated et al ..... v. Moncor Development Corporation et al  ...